Articles

Helping Patients with Multiple Myeloma Comply with Their Therapy Requires a Team Approach

By Charise Gleason, MSN, NP-C, AOCNP; Nikki Barkett, RN, BSN, OCN

Despite High Biomarker Testing Rates Result Turnaround Time Remains Treatment Decision Barrier

Successfully getting patients with multiple myeloma to follow their therapy regimen often requires a team approach. Please join Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, as they outline which team members they utilize and how they use this technique at their institutions. Read More ›

Longer Overall Survival Found in Patients with Lung Cancer Adhering to Tumor Board Recommendations

Recent survey results of physicians who treat patients with non–small-cell lung cancer reveal high biomarker testing rates, but treatment decisions frequently depend on test result turnaround time. Read More ›

No Improvement in Overall Survival Between Patients with KRAS G12C NSCLC and Patients with non-KRAS G12C NSCLC

Newly diagnosed patients who adhered to tumor board recommendations for treatment have a longer overall survival time than patients who only partially adhered or did not adhere to recommendations. Read More ›

Rechallenge with Immune Checkpoint Inhibitors in Patients with Lung Cancer Associated with More Severe Interstitial Lung Disease

Patients with KRAS G12C non–small-cell lung cancer appear to have improved progression-free survival before immunotherapy than patients with non-KRAS G12C lung cancer, but there was no improvement in overall survival between the 2 groups. Read More ›

More severe interstitial lung disease with more severe radiological features was found on second occurrence in patients with lung cancer who were rechallenged with ICI treatment. Read More ›

Accumulating Adverse Events May Cause Patients with Multiple Myeloma to Be Reluctant to Adhere to Their Treatment Plan

By Charise Gleason, MSN, NP-C, AOCNP; Nikki Barkett, RN, BSN, OCN

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, discuss how they use shared decision-making with patients to help them remain adherent to their treatment plan. Read More ›

Who Are the Patients with Multiple Myeloma Who May Not Adhere to Their Treatment Regimen?

By Charise Gleason, MSN, NP-C, AOCNP; Nikki Barkett, RN, BSN, OCN

Charise Gleason, MSN, NP-C, AOCNP, and Nikki Barkett, RN, BSN, OCN, talk about the clues and the patient characteristics that they use to determine which of their patients with multiple myeloma may be at risk for not adhering to their anticancer therapy. Read More ›

Best Practices for Keeping Patients with Multiple Myeloma Adherent to Therapy

By Charise Gleason, MSN, NP-C, AOCNP; Nikki Barkett, RN, BSN, OCN